AQSTAquestive Therapeutics, Inc.
$4.77-20% 1Y
$4.77
$2.9552 weeks$7.49
What is the market doing?
Good
1 good, 2 without dataIn an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendUptrendderived · Oct 8, 2026
In an uptrend, above its rising 50- and 200-day averages. Price is +10% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AQST is trading
Aquestive Therapeutics, Inc. is −20% over the past year while the S&P 500 is +18%: 38 points behind the market.
−20%
1-year return · S&P 500 +18%
- vs 200-day average
- +10%
vs 200-day average · a clear uptrend
- RSI (14)
- 55
RSI (14) · neutral
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-08
- $4.77
- 1 monthS&P 500 +1.6%
- −7.6%
- 1 yearS&P 500 +18%
- −20%
- 5 yearsS&P 500 +86%
- +9.4%
- vs 50-day average$4.63
- +3.0%
- 52-week high
- $7.49
- 52-week low
- $2.95
- Annualised volatility
- 76%
| Year | Return |
|---|---|
| 2026 (year to date) | −26% |
| 2025 | +81% |
| 2024 | +76% |
| 2023 | +124% |
| 2022 | −77% |
| 2021 | −27% |
| 2020 | −8.1% |
| 2019 | −7.6% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 1 of 8 | −15% |
| Feb | 8 | 4 of 8 | +10% |
| Mar | 8 | 5 of 8 | +2.6% |
| Apr | 8 | 3 of 8 | +0.93% |
| May | 8 | 2 of 8 | −1.4% |
| Jun | 8 | 4 of 8 | −3.5% |
| Jul | 8 | 5 of 8 | +11% |
| Aug | 9 | 7 of 9 | +25% |
| Sep | 9 | 2 of 9 | −4.3% |
| Oct | 9 | 6 of 9 | +4.1% |
| Nov | 8 | 5 of 8 | +19% |
| Dec | 8 | 1 of 8 | −19% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #37 of 41 by RyuScore